50 unknown. 50 Phase 1, 26 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 50 | Unknown 50 |
| Phase 2 | 26 | Unknown 26 |
Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds DERMASEAL - Skin Graft Complications | Phase 1 / Phase 2 | Unknown | Hobart W. Harris | 12 | 2024-09-01 | 2024-06-11 |
| Efficacy and Safety of Fractional CO2 Laser Combined With Intralesional Insulin, Botulinum Toxin or Triamcinolone Acetonide in the Treatment of Keloid: A Clinical, Dermoscopic and Immunohistochemical Study. Insulin group, Botulinum toxin group, Triamcinolone acetonide group - Keloid | Phase 1 / Phase 2 | Unknown | Assiut University | 45 | 2024-05-01 | 2024-01-30 |
| Ethosomal Gel Bearing Losartan 5% for Keloid Treatment Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml - Keloid | Phase 1 / Phase 2 | Unknown | Yuni Eka Anggraini | 46 | 2024-03-30 | 2023-12-05 |
| Subcutaneous Semaglutide in Systemic Scleroderma Semaglutide Pen Injector - Scleroderma, Systemic, Fibrosis | Phase 1 | Unknown | Second Xiangya Hospital of Central South University | 10 | 2024-02-29 | 2024-03-05 |
| To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis Cell therapy - Cirrhosis, Liver | Phase 1 | Unknown | Anhui Provincial Hospital | 9 | 2023-08-09 | 2024-03-06 |
| Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule Ivaltinostat, Placebo - Hematologic Malignancy, Solid Tumor | Phase 1 | Unknown | Machaon Biotherapeutics, Inc. | 32 | 2023-03-09 | 2023-10-23 |
| Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells Conventional therapy plus low dose UCMSCs treatment, Conventional therapy plus medium dose UCMSCs treatment, Conventional therapy plus high dose UCMSCs treatment - Alcoholic Cirrhosis | Phase 1 | Unknown | Yantai Yuhuangding Hospital | 36 | 2022-06-13 | 2023-03-28 |
| A Single and Repeat Dose Trial in Participants With Hepatic Impairment GB1211, Placebo - Hepatic Impairment | Phase 1 / Phase 2 | Unknown | Galecto Biotech AB | 54 | 2021-09-09 | 2023-05-11 |
| Study of Human Umbilical Cord Mesenchymal Stem Cell in Patients With Cirrhosis Due to Hepatitis B (Compensation Stage) UC-MSCs, Saline solution - Cirrhosis Due to Hepatitis B | Phase 1 / Phase 2 | Unknown | Renmin Hospital of Wuhan University | 20 | 2021-07-20 | 2022-08-19 |
| Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis Allogeneic Hepatocyte - Liver Cirrhosis | Phase 1 | Unknown | RenJi Hospital | 20 | 2021-04-20 | 2021-03-19 |
| The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 MON002 - Pulmonary Fibrosis, Interstitial Lung Disease | Phase 1 / Phase 2 | Unknown | Guy's and St Thomas' NHS Foundation Trust | 5 | 2021-03-08 | 2021-03-18 |
| Effect of Imatinib in Advance Liver Fibrosis Patients Imatinib 200mg, Placebo - Liver Fibrosis | Phase 1 / Phase 2 | Unknown | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | 20 | 2021-02-20 | 2022-02-04 |
| Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge IN01 vaccine - Pulmonary Fibrosis, Covid19 | Phase 1 | Unknown | Instituto OncolĂłgico Dr Rosell | 40 | 2020-12-01 | 2020-09-24 |
| Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium, Conditioned Medium, Triamcinolone Acetonide - Keloid | Phase 1 / Phase 2 | Unknown | PT. Prodia Stem Cell Indonesia | 24 | 2020-09-01 | 2020-07-15 |
| Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients Collagen-Polyvinylpyrrolidone - Covid19, Cytokine Storm | Phase 1 / Phase 2 | Unknown | Janette Furuzawa Carballeda | 90 | 2020-08-19 | 2021-02-17 |
| Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver Disease MSC and Tregs - Liver Cirrhosis | Phase 1 / Phase 2 | Unknown | Nanjing Medical University | 30 | 2020-06-01 | 2020-03-04 |
| Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC Cellgram™ (Bone marrow-derived MSCs) - Alcoholic Liver Cirrhosis | Phase 1 | Unknown | Pharmicell Co., Ltd. | 10 | 2019-06-20 | 2020-10-22 |
| Mesenchymal Stem Cell Therapy for Liver Cirrhosis Autologous BM MSC - Liver Cirrhosis | Phase 1 / Phase 2 | Unknown | Stem Med Pte. Ltd. | 20 | 2018-08-18 | 2021-03-17 |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Biopsy, Biospecimen Collection, Computed Tomography - Cirrhosis | Phase 1 | Unknown | National Cancer Institute (NCI) | 14 | 2018-08-09 | 2024-08-02 |
| Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to III HF-LED-RL Phototherapy, Mock Therapy - Skin Diseases, Keloid | Phase 1 | Unknown | VA Northern California Health Care System | 60 | 2018-01-31 | 2018-02-14 |
Showing 20 of 50. Sign in to see all of them.
Liver Cirrhosis (23) · Cicatrix (8) · Keloid (4) · Pulmonary Fibrosis (4) · COVID-19 (3) · End Stage Liver Disease (3) · Liver Cirrhosis, Biliary (3) · Liver Diseases (3) · Hepatitis C (2) · Liver Cirrhosis, Alcoholic (2) · Bronchiectasis (1) · Cystic Fibrosis (1) · Cytokine Release Syndrome (1) · Digestive System Diseases (1)
Pathologic Processes (50) · Pathological Conditions, Signs and Symptoms (50) · Digestive System Diseases (29) · Liver Diseases (26) · Connective Tissue Diseases (5) · Infections (5) · Liver Cirrhosis (5) · RNA Virus Infections (5) · Skin and Connective Tissue Diseases (5) · Virus Diseases (5) · Collagen Diseases (4) · Respiratory Tract Diseases (4) · Bile Duct Diseases (3) · Biliary Tract Diseases (3)
Triamcinolone Acetonide (2) · Ursodeoxycholic Acid (2) · Biopsy (1) · Cell- and Tissue-Based Therapy (1) · Colchicine (1) · Congresses as Topic (1) · Control Groups (1) · Culture Media, Conditioned (1) · Drug Therapy (1) · Fecal Microbiota Transplantation (1) · High-Energy Shock Waves (1) · Imatinib Mesylate (1) · Interferons (1) · Lamivudine (1) · MON002 (1)
Air Force Military Medical University, China (3) · Assiut University (2) · Baermed (2) · National Center for Research Resources (NCRR) (2) · AdiSave Inc. (1) · Aegeria Soft Tissue LLC (1) · Alliancells Bioscience Corporation Limited (1) · Anhui Provincial Hospital (1) · Beijing 302 Hospital (1) · Chaitanya Hospital, Pune (1) · Clinica las Condes, Chile (1) · Fast Forward Pharmaceuticals (1) · First Affiliated Hospital of Chengdu Medical College (1) · Galecto Biotech AB (1) · General Hospital of Chinese Armed Police Forces (1)
China (19) · United States (6) · United Kingdom (4) · Indonesia (2) · Netherlands (2) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Egypt (1) · India (1) · Iran (1) · Italy (1) · Mexico (1) · Puerto Rico (1)
Daiming Fan (3) · Aiwu R He (1) · Amit Patel, MD (1) · Ashish Patel, PhD FRCS (1) · Baoyong Yan, doctor (1) · Bijan Modarai, PhD FRCS (1) · Charlie Xiang, Professor (1) · Daniel Azamar-Llamas, MD (1) · David M Young, MD (1) · Eric Ochoa-Hein, MD (1) · Fengchun Zhang, MD (1) · Fu-Sheng Wang, professor (1)
PMID 10415784, PMID 12563677, PMID 14719037, PMID 15663512, PMID 17181919, PMID 18097874, PMID 19397687, PMID 19453649, PMID 19998041, PMID 21131395, PMID 22028728, PMID 22545014, PMID 22731679, PMID 24876849, PMID 26006200, PMID 26867177, PMID 28584818, PMID 30473697, PMID 30894210, PMID 31986264, PMID 32035018, PMID 32089354, PMID 32113509, PMID 32125455, PMID 32159775, PMID 32192578, PMID 32203186, PMID 32234467, PMID 32257537, PMID 32278362, PMID 32283152, PMID 32360286, PMID 32396163, PMID 33123384, PMID 34282853, PMID 38167064, PMID 39358661, PMID 9804346
2009 (1), 2014 (1), M01RR000051 (1), N01CN00035 (1), P30CA060553 (1)